denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Monday, December 9, 2024: 2:45 PM-4:15 PM
Room 7
(San Diego Convention Center)
Co-chairs:
Ming Y Lim, MBBChir, University of Utah Health
and
Rachel P. Rosovsky, MD, Massachusetts General Hospital
Disclosures:
Lim: Sanofi: Honoraria; BioMarin: Honoraria; Takeda: Honoraria. Rosovsky: Penumbra trial STORM-PE: Other: National Lead Investigator; Abbott, BMS, Dova, Inari, Inquis, Penumbra: Consultancy; Penumbra: Research Funding; The Pulmonary Embolism Response Team (PERT) Consortium: Other: President.
This new session merges the ASH Choosing Wisely Champions and the ASH Guideline Implementation Champions into a single, 90-minute session. Speakers will be selected from a pool of applicants. In addition to projects that combat overuse (previously the focus of the Choosing Wisely Champions session) and projects that highlight successful guideline implementation strategies (previously the focus of the Guideline Implementation Champions session), the call for applications for this session considers any quality improvement project (e.g., combating underuse, improving stewardship of resources, improving processes, reducing or eliminating healthcare disparities, etc.). The goal of this change is to expand opportunities to highlight high-quality quality improvement work while concentrating the focus into a single session.
See more of: Special-Interest Sessions